Acuren Net Acquisitions/Divestitures 2023-2025 | TIC

Acuren net acquisitions/divestitures from 2023 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.

Acuren Net Acquisitions/Divestitures 2023-2025 | TIC

Acuren net acquisitions/divestitures from 2023 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$229.7B
Boston Scientific (BSX)$152.7B
Stryker (SYK)$148.7B
EssilorLuxottica (ESLOY)$131.4B
Medtronic (MDT)$115.3B
Lonza Group Ag (LZAGY)$49.7B
Haleon (HLN)$44.7B
ResMed (RMD)$37.3B
Agilent Technologies (A)$35B
GE HealthCare Technologies (GEHC)$34.4B
Terumo (TRUMY)$24.6B
Koninklijke Philips (PHG)$23.1B
Insulet (PODD)$20.4B
Zimmer Biomet Holdings (ZBH)$18.6B
Baxter (BAX)$14.7B
Smith & Nephew SNATS (SNN)$13.3B
Demant (WILYY)$9B
Sunny Optical Technology (SNPTF)$8.6B
Bio-Rad Laboratories (BIO)$7B
Lantheus Holdings (LNTH)$5.6B
Perrigo (PRGO)$3.8B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
ICU Medical (ICUI)$3.3B
QuidelOrtho (QDEL)$2.1B
LeMaitre Vascular (LMAT)$1.9B
AtriCure (ATRC)$1.5B
Green Thumb Industries (GTBIF)$1.4B